This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West

Early Registration Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
February 27 - March 2, 2023San Diego Convention Center

Eric Althoff Ph.D
Director of Business Development at Seattle Children's Therapeutics


Eric has a Ph.D. in Chemistry from Columbia University and worked with David Baker at the University of Washington on the computational design of novel protein function. The success of this work resulted in four Science and Nature papers, and Eric co-founded Arzeda to commercialize the technology. WIth Arzeda still growing and now commercializing products, Eric joined Seattle Children’s a year ago to work on moving other academic technologies toward successful commercialization. The rate of development and innovation at SCTx has been mind-blowing requiring oversight of active collaborations for research and clinical trials, licensing of technologies, and finding customers for excess manufacturing capacity.

Agenda Sessions

  • Potency enhancement of CAR Ts with new genetic tools and testing quickly in clinical trials